http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021163888-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2513-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-999
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 2019-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66eece9aaba674ec0f5b41325bc8371d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c51cc1b0ce22b144945ed059a8c0d60f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e99b4498ffb424a5bd9ff4729f27776
publicationDate 2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021163888-A1
titleOfInvention Induction of myelinating oligodendrocytes in human cortical spheroids
abstract The invention described herein provides a method for generating oligocortical spheroids from (human) pluripotent stem cells. The cortical spheroids so generated produces maturing oligodendrocytes that can, for example, myelinate axons, and model myelin disease and drug effects.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11482398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023064570-A1
priorityDate 2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012177614-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57279360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 54.